醫療保健市場中的人工智慧測試、檢驗和認證（TIC）服務、機會、成長動力、產業趨勢分析和預測，2024-2032

AI Testing, Inspection and Certification (TIC) Services in Healthcare Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: 2024年07月09日 | 出版商:

Global Market Insights Inc. | 英文 300 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

隨著人工智慧與醫療設備的整合不斷增加，醫療保健市場中的人工智慧測試、檢驗和認證 (TIC) 服務預計從 2024 年到 2032 年將以超過 15% 的複合年成長率成長。

隨著創新設備在醫療保健領域首次亮相，TIC 服務對於確保人工智慧驅動的技術遵守嚴格的安全和效能基準變得至關重要。這些努力不僅推動了醫療保健技術的進步，而且優先考慮了患者的福祉。舉個例子，2024 年 6 月，Element Materials Technology 推出了 RegNav，這是其首個專為醫療器材量身訂製的人工智慧驅動的監管情報平台，強調 FDA 提高監管效率和安全性的途徑。

整個市場分為服務、類型、應用和區域。

根據類型，預計 2024 年至 2032 年，內部醫療保健市場中的 AI TIC 服務將以顯著速度成長。組織正在進行徹底的評估，以確認這些技術的準確性、安全性和可靠性，以利用受控環境進行細緻的測試和客製化解決方案

認證服務領域的人工智慧 TIC 服務在醫療保健行業的規模預計到 2032 年將以複合年成長率大幅擴張。由於服務不斷發展，各組織正在採用嚴格的認證協議來驗證人工智慧系統在醫療診斷和患者護理方面的性能，以應對新的挑戰並維護監管合規性。

從地區來看，亞太地區醫療保健市場規模的人工智慧TIC 服務預計將在2024 年至2032 年間出現強勁成長，這主要歸因於醫療保健支出的不斷增加以及診斷、治療和患者管理人工智慧技術的進步。這些發展為複雜的人工智慧解決方案的整合鋪平了道路，以提高該地區醫療保健服務的品質和可靠性。

產業生態系統分析
供應商格局
- 供應商
- TIC 服務提供者
- 人工智慧技術提供者
- 配銷通路
- 最終用戶
利潤率分析
技術與創新格局
專利分析
重要新聞和舉措
監管環境
衝擊力
- 成長動力
  - 醫療保健服務需求不斷成長
  - 人工智慧和醫療保健領域的技術進步
  - 醫療保健行業不斷提高的監管要求和品質標準
  - 醫療產品的複雜性日益增加
- 產業陷阱與挑戰
  - 複雜的監管環境
  - 初始成本高且投資報酬率不確定
成長潛力分析
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
競爭定位矩陣
戰略展望矩陣

第 5 章：市場估計與預測：按服務分類，2021-2032 年

主要動力向：按服務
測試
檢查
認證
其他

第 6 章：市場估計與預測：按類型，2021-2032

主要動向：依類型
內部
外包

第 7 章：市場估計與預測：按應用分類，2021-2032 年

主要動向：按應用
製藥和生物技術
臨床實驗室和診斷
醫院和醫療機構
醫療器材

第 8 章：市場估計與預測：按地區，2021-2032 年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 法國
- 義大利
- 西班牙
- 俄羅斯
- 北歐人
- 歐洲其他地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 澳新銀行
- 東南亞
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
MEA
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- MEA 的其餘部分

第 9 章：公司簡介

AFNOR Group
Apave International
Applus Services, S.A
BSI Group
Bureau Veritas
Cofrac (Comite Francais d'Accreditation)
DEKRA SE
DNV GL
Emitech Group
Eurofins Scientific
Expleo
Intertek Group PLC
LNE (Laboratoire National de Metrologie et d'Essais)
Merieux NutriSciences
Pharmasafe
QualiTest
SGS Group
TUV Rheinland
TUV SUD
UL (Underwriters Laboratories)

簡介目錄

Product Code: 10167

AI Testing, Inspection, and Certification (TIC) Services in Healthcare Market size is anticipated to expand at over 15% CAGR from 2024 to 2032, led by increasing launches along with integration of AI with medical devices.

As innovative devices are making their debut in the healthcare sector, TIC services have grown pivotal for ensuring AI-driven technologies adhere to stringent safety and performance benchmarks. These efforts not only propel advancements in healthcare technology but also prioritize patient well-being. To cite an example, in June 2024, Element Materials Technology unveiled RegNav, its inaugural AI-driven regulatory intelligence platform tailored for medical devices, emphasizing FDA pathways to bolster regulatory efficiency and safety.

The overall market is segregated into service, type, application, and region.

Based on type, the AI TIC services in healthcare market value from the in-house segment is estimated to rise at a notable rate from 2024 to 2032. This is fueled by the escalating demand to uphold stringent standards for AI-driven medical devices. Organizations are undertaking thorough evaluations to affirm the accuracy, safety, and reliability of these technologies for leveraging a controlled environment for meticulous testing and bespoke solutions

AI TIC services in healthcare industry size from the certification service segment is anticipated to expand at a substantial CAGR up to 2032. This expansion is driven by the increasing imperative to guarantee the reliability and safety of AI technologies. Organizations are adopting stringent certification protocols to validate the performance of AI systems in medical diagnostics and patient care on account of evolving services to tackle new challenges and uphold regulatory compliance.

Regionally, the Asia Pacific AI TIC services in healthcare market size is expected to depict robust growth between 2024 and 2032, largely attributed to escalating healthcare expenditures as well as spurring advancements in AI technologies for diagnostics, treatment, and patient management. These developments are paving the way for the integration of sophisticated AI solutions to elevate the quality and reliability of healthcare services in the region.

Chapter 1 Methodology and Scope

1.1 Research design
- 1.1.1 Research approach
- 1.1.2 Data collection methods
1.2 Base estimates and calculations
- 1.2.1 Base year calculation
- 1.2.2 Key trends for market estimates
1.3 Forecast model
1.4 Primary research and validation
- 1.4.1 Primary sources
- 1.4.2 Data mining sources
1.5 Market definitions

Chapter 2 Executive Summary

2.1 Industry 360° synopsis, 2021-2032

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Supplier landscape
- 3.2.1 Suppliers
- 3.2.2 TIC service providers
- 3.2.3 AI technology providers
- 3.2.4 Distribution channel
- 3.2.5 End users
3.3 Profit margin analysis
3.4 Technology and innovation landscape
3.5 Patent analysis
3.6 Key news and initiatives
3.7 Regulatory landscape
3.8 Impact forces
- 3.8.1 Growth drivers
  - 3.8.1.1 Growing demand for healthcare services
  - 3.8.1.2 Technological advancements in AI and healthcare
  - 3.8.1.3 Increasing regulatory requirements and quality standards in healthcare industry
  - 3.8.1.4 Increasing complexity of medical products
- 3.8.2 Industry pitfalls and challenges
  - 3.8.2.1 Complex regulatory environment
  - 3.8.2.2 High initial costs and ROI uncertainty
3.9 Growth potential analysis
3.10 Porter's analysis
3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategic outlook matrix

Chapter 5 Market Estimates and Forecast, By Service, 2021-2032 ($ Bn)

5.1 Key trends, by service
5.2 Testing
5.3 Inspection
5.4 Certification
5.5 Others

Chapter 6 Market Estimate and Forecast, By Type, 2021-2032 ($ Bn)

6.1 Key trends, by type
6.2 In-house
6.3 Outsourced

Chapter 7 Market Estimates and Forecast, By Application, 2021-2032 ($ Bn)

7.1 Key trends, by application
7.2 Pharmaceuticals and biotechnology
7.3 Clinical laboratories and diagnostics
7.4 Hospitals and healthcare facilities
7.5 Medical devices

Chapter 8 Market Estimates and Forecast, By Region, 2021-2032 ($ Bn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 UK
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 Italy
- 8.3.5 Spain
- 8.3.6 Russia
- 8.3.7 Nordics
- 8.3.8 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 India
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 ANZ
- 8.4.6 Southeast Asia
- 8.4.7 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 MEA
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Rest of MEA